Austrian Biobanking Study for Sarcopenia
Recruiting
Observational Study
Sarcopenia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Medical University of Graz · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators aim to set up a biobanking study in Graz, Austria, to study sarcopenia in liver cirrhosis and chronic inflammatory bowel disease by collecting a standardized dataset including routine clinical and biochemical tests; biosamples to assess novel biomarker as well as advanced clinical assessments. In a small country like Austria, a nationwide biobanking study can enhance research eno…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \>18y
* Informed consent
* CT/MRI scan as part of routine care within +/-2 month of the study visit
Exclusion Criteria:
* Hepatic encephalopathy \> grade 2 and or other cognitive disorder not allowing informed consent
* Hepatocellular carcinoma stage BCLC C or D
* Any ot…
Contacts
Lavra Celcer, MSc
CONTACT